Sangamo is a biopharma company focused on the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs.
Sangamo is a biopharma company focused on the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs.
DNA-directed RNA Interference (ddRNAi) is Benitec’s RNAi platform for gene silencing, with several advantages over other methods of gene silencing such as siRNA, anti-sense and zinc finger nucleases.